- ホーム
- アプリ分析
- Pigio™: Gaze-to-Speech
- Pigio™: Gaze-to-Speech Vs. Eye Gaze Communication Board
Pigio™: Gaze-to-Speech vs Eye Gaze Communication Board使用状況と統計
Pigio™ is your handsfree gateway to connect you to the digital world. Simply move your eyes across the interface until you come to the desired command where you gaze to click.
If you are unable to speak due to mobility issues or any other medical conditions requiring hospitalization, Pigio™ not only allows you to communicate but keeps you informed. If you are a healthcare professional or caregiver and want to improve the quality of life of your patients, you can consider Pigio™ as the new affordable way to access the digital world.
Pigio™ turns your iPad into a communication and information hub. Using our innovative eye-tracking technology, Pigio™ allows you to type custom messages using a virtual keyboard and read the latest news from a variety of sources.
Contrary to infrared eye-tracking solutions, Pigio™ calibration is quick and works even if the user is wearing glasses or in a sunny environment.
Multilingual (English, French, Spanish).
End user licence agreement: https://innodemneurosciences.com/eula
Privacy Policy: https://innodemneurosciences.com/privacy-policy
- Apple App ストア
- 無料
- 医学
ストアランキング
- -
This app allows users with to select phrases and icons on a Communication Board with just their eyes. To select icons simply keep your head still and look all the way left, right, or up. In the settings menu users can adjust the sensitivity and time delays, select between different voice options, and even change the images.
- Apple App ストア
- 無料
- ヘルス & フィットネス
ストアランキング
- -
Pigio™: Gaze-to-Speech対Eye Gaze Communication Boardランキング比較
と過去28日間の Pigio™: Gaze-to-Speech ランキング傾向を比較 Eye Gaze Communication Board
ランキング
ご利用可能なデータがありません
Pigio™: Gaze-to-Speech 対 Eye Gaze Communication Board 国の比較によるランキング
と過去28日間の Pigio™: Gaze-to-Speech ランキング傾向を比較 Eye Gaze Communication Board
表示できるデータはありません
無料トライアルで任意のサイトと比較する
Pigio™: Gaze-to-Speech VS.
Eye Gaze Communication Board
12月 23, 2024